MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD), a frontrunner in innovative medical technology, has declared it will unveil its financial results for the fourth quarter and the full year of 2025 on March 18, 2026. The announcement is set to occur before the stock markets open, marking a significant occasion for stakeholders eager to assess the company's performance.
Mark Grant, the President and Chief Executive Officer of Lifeward, alongside Almog Adar, the Chief Financial Officer, will lead a conference call and live webcast at 8:30 a.m. EST. During this session, they will delve into the financial results, offering insights that may influence investor sentiment and market performance. The live call can be accessed by analysts and investors using various toll-free numbers, ensuring broad participation. Learn more on Investopedia.
For those in the U.S., the toll-free number is 1-833-316-0561, while international participants can dial 1-412-317-0690. German investors can use 0800-6647650, and those in Israel can reach out at 1-80-9212373. Callers are encouraged to reference the "Lifeward Earnings Call" for identification purposes.
Accessing the Live Webcast
The conference call will also be available via a live webcast, which can be accessed through a link on Lifeward's official website, GoLifeward.com, in the "Investors" section. Interested parties can access the following direct link: https://edge.media-server.com/mmc/p/yc9qmwr7. Following the live event, an archived version of the webcast will be made available on the Company's website, allowing for continued access to the insights shared.
This forthcoming earnings report is highly anticipated, given Lifeward's commitment to advancing innovative medical technologies that cater to individuals with physical limitations or disabilities. The company has built a reputation for its groundbreaking products, which include the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit. Each of these innovations is designed to facilitate recovery and enhance quality of life for users.
Lifeward's Commitment to Innovation
Founded in 2001, Lifeward has established itself as a leader in the medical technology sector, with operations extending across the United States, Israel, and Germany. The company's mission centers on relentless innovation aimed at transforming the lives of those with disabilities. This commitment to excellence is not just a corporate mantra; it is reflected in the extensive research and development efforts that underpin their product offerings.
As Lifeward prepares for the upcoming earnings announcement, investors are keen to learn how the company's innovative strategies have impacted financial performance. In recent years, Lifeward has invested heavily in enhancing its product lines and expanding its market reach, which may be reflected in their financial results. The upcoming call and webcast will provide a platform for the company to articulate its growth strategies and financial health.
Market Expectations and Future Prospects
Market analysts will closely scrutinize the financial results for signs of growth, profitability, and overall business health. Given the competitive landscape of medical technology, Lifeward's ability to maintain and expand its market share will be a focal point for investors. The results may also shed light on how external factors, such as regulatory changes and market demand, have influenced Lifeward's operations over the past year.
In the lead-up to the earnings announcement, stock performance and investor sentiment may fluctuate as stakeholders assess the potential implications of Lifeward's financial health. The conference call will likely address questions regarding product development, market expansion, and the ongoing evolution of Lifeward's innovative offerings. Such discussions are pivotal as they provide clarity on the company's trajectory and the strategic initiatives aimed at driving future growth.
As Lifeward gears up for this significant event, the medical technology community watches closely. The insights shared on March 18 will not only inform investors but also highlight Lifeward's ongoing commitment to transforming lives through innovative solutions. With a strong portfolio of products and a dedication to excellence, Lifeward is well-positioned to navigate the challenges and opportunities ahead.
Originally reported by Globe Newswire. View original.